作者: John Stover , Carel Pretorius , Kyeen Andersson
DOI: 10.1007/978-1-4614-6507-2_9
关键词: Risk compensation 、 HIV vaccine 、 Scale (social sciences) 、 Male circumcision 、 Business 、 National Policy 、 Transmission (medicine) 、 Emerging technologies 、 Human immunodeficiency virus (HIV) 、 Economic growth
摘要: Research has shown that several new technologies can be effective in reducing the transmission of HIV infection. Male circumcision was to reduce susceptibility infection by about 60% trials 2005 and 2007. In 2009, a large scale trial an vaccine showed some protective benefits. results released 2010 effectiveness oral pre-exposure prophylaxis topical at levels around 40%. When become available national policy makers are faced with questions whether implement them, how much they will cost should implemented. Funders face similar questions. We have developed computer models aid development planning. These intended investigate such as “What impact terms infections averted?”, “How would program cost?”, “Would cost-effective?” This chapter discusses for male circumcision, prophylaxis, vaccines their applications inform makers.